Email alerts
Advanced Search
  • Jun 12, 2014
    Medtronic CoreValve® System Receives FDA Approval for Patients at High Risk for Surgery
    Accelerated Approval Obtained after Clinical Outcomes with Self-Expanding Valve Prove Superior to Surgical Aortic Valve Replacement at One Year

    MINNEAPOLIS - June 12, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for patients...

  • Jun 11, 2014
    Medtronic Announces Date for 2014 Annual Meeting
    Shareholders Invited to Attend Annual Meeting on Aug. 21, 2014

    MINNEAPOLIS - June 11, 2014 - The board of directors of Medtronic, Inc. (NYSE: MDT), announced that the company's annual meeting of shareholders will be held at 10:30 a.m. CDT on Thursday, Aug....

  • Jun 11, 2014
    Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease
    Global Leader Projects Introduction of IN.PACT Admiral Drug-coated Balloon to U.S. Market in Early FY16

    MINNEAPOLIS - Date - Moving toward U.S. market introduction of its novel medical device to treat peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced that it recently submitted...

  • Jun 10, 2014
    Covidien Neurovascular Micro Catheter Receives FDA Approval
    Apollo™ Onyx™ Delivery Micro Catheter with Detachable Tip Enhances Onyx™ Liquid Embolic System (LES) Delivery

    DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 10, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration (FDA) approval of its Apollo™ Onyx™ delivery micro catheter - the...

  • Jun 10, 2014
    Medtronic CFO Gary Ellis to Speak at Wells Fargo Healthcare Conference

    MINNEAPOLIS - June 10, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Healthcare Conference on Tuesday,...

Show 5102550100 per page